Sanofi, Long-Time Leader In Diabetes, Is Exiting Diabetes Research

 
• By Jessica Merrill
  
Lyon France, 3 October 2017: White logo of the french multinational pharmaceutical company Sanofi on their glass office building in Lyon France
Sanofi Plans To Discontinue Diabetes And Cardiovascular Disease Research.
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapeutic Category